Keywords: MR-Guided Focused Ultrasound, Focused Ultrasound, Hyperthermia, focused ultrasound, bone metastasis
Motivation: Mild hyperthermia (HT) induced by magnetic resonance-guided focused ultrasound (MRgHIFU) before radiation therapy (RT) could act as adjuvant in pain relief for bone metastasis.
Goal(s): This study aims to evaluate the feasibility and safety of MRgHIFU procedure in one patient with a posterior right acetabulum
Approach: The target temperature elevation was 6°C. The targeting and temperature monitoring in near real-time were performed by MRI.
Results: The temperature elevation lasting 30-minutes was 6.01°C on average in bone metastasis. The MR-guidance allowed a safe and successful procedure without adverse events. The 25-minutes between HT end point and RT demonstrated the technical feasibility of the procedure.
Impact: This study is a first step to demonstrate MRgHIFU hyperthermia adjuvant to palliative radiotherapy of bone metastases. The non-invasive, safe and accurate use of focused ultrasound to sensitize tumors opens the way to more efficient application of the radiation dose.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords